Internal Medicine, Infectious Disease · Thousand Oaks, CA
NPI
1184712168
Since 2006
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
2220 Lynn Rd, Suite 301
Thousand Oaks, CA, 91360
Phone (805) 495-1073
Groups this clinician bills Medicare through
Medicare paid, 2024
$390K
72,620 services
Medicare patients, 2024
676
Average age 77
Drug cost, 2024
$789K
2,005 prescriptions
Company payments, 2025
$3,330
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sujay Dutta was code J0878 (injection, daptomycin, 1 mg), 61,501 times for 19 patients. In total Sujay Dutta billed 72,620 services in 51 codes, and Medicare paid $390K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-03-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0878 Injection, daptomycin, 1 mg | Office | 61,501 | 19 | $0.04 | $2,509 |
| 99232 Hospital E&M - Subsequent | Facility | 1,132 | 300 | $63.01 | $71K |
| J0696 Injection, ceftriaxone sodium, per 250 mg | Office | 876 | 26 | $0.35 | $310 |
| 99213 Office E&M - Established | Facility | 697 | 111 | $51.56 | $36K |
| 99213 Office E&M - Established | Office | 604 | 207 | $75.06 | $45K |
| 96365 Intravenous Infusion, Hydration | Office | 495 | 82 | $56.11 | $28K |
| J1335 Injection, ertapenem sodium, 500 mg | Office | 490 | 36 | $8.74 | $4,283 |
| 99233 Hospital E&M - Subsequent | Facility | 315 | 139 | $94.55 | $30K |
| 99223 Hospital E&M - Initial | Facility | 229 | 213 | $138.13 | $32K |
| 36415 Venipuncture Blood Collection | Office | 118 | 59 | $8.65 | $1,021 |
| 99308 SNF E&M | Facility | 92 | 21 | $60.57 | $5,572 |
| 99203 Office E&M - New | Facility | 26 | 26 | $64.65 | $1,681 |
| 99204 Office E&M - New | Office | 25 | 25 | $140.82 | $3,520 |
| 99305 SNF E&M | Facility | 22 | 18 | $109.40 | $2,407 |
| 99214 Office E&M - Established | Office | 19 | 17 | $102.65 | $1,950 |
By year: 2022 $267K for 4,733 services; 2023 $288K for 8,788 services; 2024 $390K for 72,620 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 118 | 59 | $8.65 | $1,021 |
Medicare prescription drug claims, 2024
In 2024, the drug Sujay Dutta prescribed most often to Medicare patients was Sulfamethoxazole-Trimethoprim (Sulfamethoxazole/Trimethoprim), with 144 prescriptions and refills. In total Sujay Dutta wrote 2,005 Medicare prescriptions that cost $789K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 144 | 177 | 52 | $1,346 |
| Cefuroxime Cefuroxime Axetil | 102 | 146 | 39 | $3,862 |
| Cephalexin Generic | 92 | 118 | 36 | $2,135 |
| Ceftriaxone Ceftriaxone Sodium | 88 | 88 | 21 | $16K |
| Ciprofloxacin Hcl Generic | 82 | 82 | 53 | $940 |
| Vancomycin Hcl Generic | 77 | 77 | 21 | $11K |
| Amoxicillin Generic | 74 | 108 | 37 | $925 |
| Daptomycin Generic | 74 | 74 | 16 | $91K |
| Azithromycin Generic | 64 | 95 | 22 | $1,050 |
| Doxycycline Hyclate Generic | 54 | 66 | 28 | $1,217 |
| Fluconazole Generic | 52 | 70 | 18 | $1,324 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 42 | 44 | 27 | $496 |
| Mupirocin Generic | 41 | 45 | 29 | $224 |
| Meropenem Generic | 31 | 31 | Under 11 | $11K |
| Sodium Chloride 0.9 % Sodium Chloride | 30 | 30 | Under 11 | $1,454 |
Brand drugs: - claims; generic drugs: 1,724 claims; opioid claims: 27.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sujay Dutta $3,330 ($3,330 in general payments such as food, travel and fees) from 8 companies. The largest payer was ETS Wound Care LLC with $2,822.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.